The aim of this study was to identify genomic alterations in BRCA1/BRCA2 wild-type tumor samples from women with family history strongly suggestive of hereditary breast/ovarian cancer. The gene discussed is BRCA2; the disease is Hereditary breast and ovarian cancer syndrome.